Přejít k obsahu
Merck
Všechny fotografie(1)

Key Documents

75423

Millipore

Vancomycin supplement

suitable for microbiology

Synonyma:

Vancomycin hydrochloride

Přihlásitk zobrazení cen stanovených pro organizaci a smluvních cen


About This Item

Empirický vzorec (Hillův zápis):
C66H75Cl2N9O24 · xHCl
Číslo CAS:
Molekulová hmotnost:
1449.25 (free base basis)
UNSPSC Code:
41171614
NACRES:
NA.85

agency

according to GB 4789.40-2016
according to ISO 22964:2017

Quality Level

sterility

sterile

form

powder

shelf life

limited shelf life, expiry date on the label

application(s)

environmental
food and beverages

microbiology

storage temp.

2-8°C

suitability

Enterobacter spp.

InChI

1S/C66H75Cl2N9O24.ClH/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92;/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95);1H/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-;/m0./s1

InChI key

LCTORFDMHNKUSG-XTTLPDOESA-N

Hledáte podobné produkty? Navštivte Průvodce porovnáváním produktů

Application

Vancomycin supplement is an antibiotic supplement recommended by ISO Committee for selective enrichment of Enterobacter sakazakii. It has been used as a supplement in a selective media to study the presence of vancomycin resistant enterococci in the treated effluent of wastewater treatment plants.

Components

(per vial, sufficient for 1000 ml medium)
Vancomycin 10.00 mg

related product

Č. produktu
Popis
Stanovení ceny

pictograms

Health hazard

signalword

Danger

hcodes

Hazard Classifications

Resp. Sens. 1 - Skin Sens. 1

Storage Class

11 - Combustible Solids

wgk_germany

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Faceshields, Gloves


Vyberte jednu z posledních verzí:

Osvědčení o analýze (COA)

Lot/Batch Number

Nevidíte správnou verzi?

Potřebujete-li konkrétní verzi, můžete vyhledat daný certifikát podle čísla dávky nebo čísla šarže.

Již tento produkt vlastníte?

Dokumenty související s produkty, které jste v minulosti zakoupili, byly za účelem usnadnění shromážděny ve vaší Knihovně dokumentů.

Navštívit knihovnu dokumentů

Christine Dieterich et al.
Toxicological sciences : an official journal of the Society of Toxicology, 107(1), 258-269 (2008-10-22)
Vancomycin, one of few effective treatments against methicillin-resistant Staphylococcus aureus, is nephrotoxic. The goals of this study were to (1) gain insights into molecular mechanisms of nephrotoxicity at the genomic level, (2) evaluate gene markers of vancomycin-induced kidney injury, and
Klas I Udekwu et al.
The Journal of antimicrobial chemotherapy, 63(4), 745-757 (2009-02-17)
To determine the functional relationship between the density of bacteria and the pharmacodynamics of antibiotics, and the potential consequences of this inoculum effect on the microbiological course of antibiotic treatment of Staphylococcus aureus infections. In vitro time-kill, MIC estimation and
Screening municipal wastewater effluent and surface water used for drinking water production for the presence of ampicillin and vancomycin resistant enterococci
Maja Taucer-Kapteijn
International Journal of Hygiene and Environmental Health, 4-5, 437-442 (2016)
Vancomycin use in neonates and children: evidence-based practice is needed.
Helen M Sammons et al.
Archives of disease in childhood, 98(6), 447-448 (2013-04-18)
Oliver A Cornely et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(19), 2493-2499 (2013-05-30)
Patients with cancer are at increased risk for Clostridium difficile-associated diarrhea (CDAD). Little is known about treatment response. Two double-blind trials randomly allocated 1,105 patients with CDAD to fidaxomicin or vancomycin treatment (modified intent-to-treat [mITT]), and 183 of these had

Náš tým vědeckých pracovníků má zkušenosti ve všech oblastech výzkumu, včetně přírodních věd, materiálových věd, chemické syntézy, chromatografie, analytiky a mnoha dalších..

Obraťte se na technický servis.